Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
CARGO Therapeutics, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$1.06 | -$0.58 | -$0.78 |
| Q2 2025 | 2 | -$0.65 | -$0.65 | -$0.65 |
| Q3 2025 | 2 | -$0.55 | -$0.55 | -$0.55 |
| Q4 2025 | 3 | -$0.49 | -$0.49 | -$0.49 |
| Q1 2026 | 2 | -$0.20 | -$0.20 | -$0.20 |
| Q2 2026 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q3 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q4 2026 | 2 | -$0.26 | -$0.26 | -$0.26 |
| Q1 2027 | 2 | -$0.43 | -$0.43 | -$0.43 |
| Q2 2027 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q3 2027 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q4 2027 | 2 | -$0.34 | -$0.34 | -$0.34 |
CARGO Therapeutics, Inc. Common Stock Earnings Date And Information
CARGO Therapeutics, Inc. Common Stock last posted its earnings results on Wednesday, March 12th, 2025. The company reported $-0.95 earnings per share for the quarter, missing analysts' consensus estimates of $-0.95 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. CARGO Therapeutics, Inc. Common Stock has generated $-4 earnings per share over the last year ($-3.72 diluted earnings per share) and currently has a price-to-earnings ratio of -1.08. CARGO Therapeutics, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based on prior year's report dates.
CARGO Therapeutics, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/12/2025 | Q4 2024 | -$0.95 | -$1.01 | -0.06 | $0 | $0 |
| 11/12/2024 | Q3 2024 | -$1.14 | -$0.88 | 0.26 | $0 | $0 |
| 08/12/2024 | Q2 2024 | -$1.06 | -$1.02 | 0.04 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$1.05 | -$0.87 | 0.18 | N/A | $0 |
| 03/21/2024 | Q4 2023 | -$1.62 | -$0.78 | 0.84 | N/A | $0 |
| 12/13/2023 | Q3 2023 | -$2.78 | -$0.92 | 1.86 | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.46 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.33 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.47 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.63 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CARGO Therapeutics, Inc. Common Stock Earnings: FAQ's
CARGO Therapeutics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based offlast year's report dates.
The conference call for CARGO Therapeutics, Inc. Common Stock's latest earnings report can be listened to online.
The conference call transcript for CARGO Therapeutics, Inc. Common Stock's latest earnings report can be read online.
CARGO Therapeutics, Inc. Common Stock (:CRGX) has a recorded net income of $-167,502,000.CARGO Therapeutics, Inc. Common Stock has generated $-3.72 earnings per share over the last four quarters.
CARGO Therapeutics, Inc. Common Stock (:CRGX) has a price-to-earnings ratio of -1.08 and price/earnings-to-growth ratio is 0.17.